15:00 ETBioOra and Cincinnati Children's Hospital Medical Center Partner to Advance Next-Generation CAR-T Therapy for Children with Leukaemiaprnewswire·Apr 13 at 02:00 PMBIORQ0.00%BIOR0.00%
BioOra and Octane Biotech Sign Letter of Intent to Expand Cell Therapy Manufacturing Using the Cocoon® Platformbiopharmadive·Apr 7 at 09:18 AMBIB+12.71%BIOR0.00%
Bora Biologics Successfully Completes 2,000L Engineering and Scale-Up Run in San Diego, Reinforcing Commercial-Scale ReadinessMorningStar·Apr 6 at 07:05 AMTBPH+0.24%IXJ+3.32%
UPSHER-SMITH LAUNCHES GENERIC VERSION OF CIPRODEX® (CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1%) STERILE OTIC SUSPENSION | BORAY Stock NewsStockTitan·Apr 6 at 05:05 AMBMRN+3.49%BBH+8.70%
08:50 ETInside information: Bioretec Ltd's Board of Directors resolved on a rights issue of up to approximately EUR 14.8 million and publishes the terms and conditions of the rights issueprnewswire·Mar 27 at 07:52 AMBIORQ0.00%BIOR0.00%
12:07 ETBioretec Ltd's Financial Statements and Annual Report 2025 publishedprnewswire·Mar 13 at 11:08 AMBIORQ0.00%BIOR0.00%
16:13 ETNotice of the Extraordinary General Meeting of Bioretec Ltdprnewswire·Mar 10 at 03:13 PMBIOR0.00%BIORQ0.00%
Bioretec Ltd's financials for Jan-Dec 2025: Net sales EUR 3,522k (-22.5% vs 2024), EBITDA EUR -8,476k. Strategy update for 2026–2028.Unusual Whales·Feb 13 at 02:07 AMBIOR0.00%BIORQ0.00%
Biora Therapeutics completes restructuring process, now privately held; aims to speed up BioJet™ platform development.Unusual Whales·May 8, 2025 at 04:52 PMBIORQ0.00%BIOR0.00%
Biora Therapeutics finishes restructuring, now privately held with funds to boost BioJet™ platform development.Unusual Whales·May 4, 2025 at 02:33 PMBIOR0.00%BIORQ0.00%
Biora Therapeutics exits restructuring as a private company, securing funding to advance BioJet™ platform.Unusual Whales·Apr 19, 2025 at 06:07 PMBIOR0.00%BIORQ0.00%
